Fear of cancer recurrence, distress, and quality of life in adolescent and young adult cancer survivors
Abstract
Adolescents and young adult cancer survivors often experience high levels of fear of cancer recurrence (FCR), which significantly impacts their emotional well-being and quality of life. The lack of studies on this target population in Portugal leads to a gap of knowledge that informs the development of interventions and solutions aimed at AYA cancer survivors. This study aimed to analyze the moderating effect of FCR on the relationship between emotional distress and quality of life in AYA surviving cancer. This is a cross-sectional study including 96 participants between the ages of 15 and 25 at the time of diagnosis. Sociodemographic, clinical, and psychosocial characteristics were collected through a sociodemographic and clinical questionnaire, the FCR7 scale, the Hospital Anxiety and Depression Scale (HADS), and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-30 (EORTC QLQ-C30). We analyzed correlations between FCR and clinical, sociodemographic factors and tested the direct and indirect relationships between FCR, distress, and quality of life. The results indicated that high levels of FCR were associated with lower emotional functioning, and gender was the only sociodemographic variable significantly associated with FCR. Although anxiety was found to influence emotional functioning in AYAs, FCR did not moderate the relationship between anxiety and emotional functioning. This study allows us to gain more knowledge about the psychological impact of the disease on this population.
Copyright (c) 2025 Author(s)

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Shay LA, Carpentier MY, Vernon SW. Prevalence and correlates of fear of recurrence among adolescent and young adult versus older adult post-treatment cancer survivors. 2016; 24(11): 4689–4696.
World Health Organization (WHO). Cancer. Available online: https://www.who.int/health-topics/cancer#tab = tab_1 (accessed on 25 March 2025).
Crist JV, Grunfeld EA. Factors reported to influence fear of recurrence in cancer patients: A systematic review. Psycho-Oncology. 2013; 22(5): 978–986.
Simard S, Thewes B, Humphris G, et al. Fear of cancer recurrence in adult cancer survivors: A systematic review of quantitative studies. Journal of Cancer Survivorship. 2013; 7(3): 300–322.
Walburg V, Rueter M, Lamy S, et al. Fear of cancer recurrence in Non- and Hodgkin lymphoma survivors during their first three years of survivorship among French patients. Psychology, Health and Medicine. 2019; 24(7): 781–787.
Jones JM, Fitch M, Bongard J, et al. The needs and experiences of post-treatment adolescent and young adult cancer survivors. Journal of Clinical Medicine. 2020; 9(5).
Vandraas KF, Reinertsen KV, Kiserud CE, Lie HC. Fear of cancer recurrence among young adult cancer survivors—exploring long-term contributing factors in a large, population-based cohort. Journal of Cancer Survivorship. 2021; 15(4): 497–508.
Luo X, Li W, Yang Y, et al. High fear of cancer recurrence in Chinese newly diagnosed cancer patients. Frontiers in Psychology. 2020; 11.
Götze H, Taubenheim S, Dietz A, et al. Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long-term cancer survivors. Psycho-Oncology. 2019; 28(10): 2033–2041.
Thewes B, Bell ML, Butow P, et al. Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: Results of a cross-sectional study. Psycho-Oncology. 2013; 22(12): 2797–2806.
Almeida SN, Elliott R, Silva ER, Sales CMD. Fear of cancer recurrence: A qualitative systematic review and meta-synthesis of patients’ experiences. Clinical Psychology Review. 2019; 68: 13–24.
Lebel S, Ozakinci G, Humphris G, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Supportive Care in Cancer. 2016; 24(8): 3265–3268.
Liu J, Peh CX, Simard S, et al. Beyond the fear that lingers: The interaction between fear of cancer recurrence and rumination in relation to depression and anxiety symptoms. Journal of Psychosomatic Research. 2018; 111: 120–126.
Mutsaers B, Jones G, Rutkowski N, et al. When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence. Supportive care in cancer. 2016; 24(10): 4207–4218.
Rha SY, Park JS, Choi YY, et al. Fear of cancer recurrence and its predictors and outcomes among cancer survivors: a descriptive correlational study. European Journal of Oncology Nursing. 2022; 58.
Handschel J, Naujoks C, Kübler NR, Krüskemper G. Fear of recurrence significantly influences quality of life in oral cancer patients. Oral Oncology. 2012; 48(12): 1276–1280.
Chen WY, Wang S, Peng X, Zhu Y. Trait emotional intelligence and quality of life among breast cancer patients: the mediating role of fear of cancer recurrence. International Journal of Nursing Practice. 2022; 28(4).
Lang MJ, David V, Giese-Davis J. The age conundrum: A scoping review of younger age or adolescent and young adult as a risk factor for clinical distress, depression, or anxiety in cancer. Journal of Adolescent and Young Adult Oncology. 2015; 4(4): 157–173.
Adolescent and Young Adult Oncology Progress Review Group. Closing the gap: Research and care imperatives for adolescents and young adults with cancer. Available online: https://www.cancer.gov/types/aya/research/ayao-august-2006.pdf (accessed on 25 March 2025).
Organização das Nações Unidas (ONU). Statistics on youth (Portuguese). Available online: https://unric.org/pt/juventude/ (accessed on 25 March 2025).
Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: Cancer today. Available online: https://gco.iarc.fr/today (accessed on 25 March 2025).
Sun H, Yang Y, Zhang J, et al. Fear of cancer recurrence, anxiety and depressive symptoms in adolescent and young adult cancer patients. Neuropsychiatric Disease and Treatment. 2019; 15: 857–865.
Osmani V, Hörner L, Klug SJ, Tanaka LF. Prevalence and risk of psychological distress, anxiety and depression in adolescent and young adult (AYA) cancer survivors: A systematic review and meta‐analysis. Cancer Medicine. 2023; 12(17): 18354–18367.
Teo T, Ling Poon EY. P30-2 A scoping review on prevalence of anxiety and depression (AnD) in adolescent and young adult cancer (AYAO) patients. Annals of Oncology. 2024; 35: S1375.
Luigjes-Huizer YL, Tauber NM, Humphris G, et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? a systematic review and individual participant data meta-analysis. Psycho-Oncology. 2022; 31(6): 879–892.
Loughan AR, Lanoye A, Aslanzadeh FJ, et al. Fear of Cancer Recurrence and Death Anxiety: Unaddressed Concerns for Adult Neuro-oncology Patients. Journal of Clinical Psychology in Medical Settings. 2021; 28(1): 16–30.
Mattsson E, Einhorn K, Ljungman L, et al. Women treated for gynaecological cancer during young adulthood–A mixed-methods study of perceived psychological distress and experiences of support from health care following end-of-treatment. Gynecologic Oncology. 2018; 149(3): 464–469.
Yang Y, Li W, Wen Y, et al. Fear of cancer recurrence in adolescent and young adult cancer survivors: A systematic review of the literature. Psycho-Oncology. 2019; 28(4): 675–686.
Humphris GM, Watson E, Sharpe M, Ozakinci G. Unidimensional scales for fears of cancer recurrence and their psychometric properties: the FCR4 and FCR7. Health and Quality of Life Outcomes. 2018; 16(1).
Neves MC, Sales CMD, Oliveira J, et al. Assessing Fear of Cancer Recurrence among Adolescents and Young Adults: The Portuguese Validation and Psychometric Assessment of the “Fear of Cancer Recurrence 7” Scale. Acta Médica Portuguesa. 2025; 38(3): 148–159.
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983; 67(6): 361–370.
Pais-Ribeiro J, Silva I, Ferreira T, et al. Validation study of a Portuguese version of the Hospital Anxiety and Depression Scale. Psychology, Health and Medicine. 2007; 12(2): 225–237.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. JNCI: Journal of the National Cancer Institute. 1993; 85(5): 365–376.
Pais-Ribeiro J, Pinto C, Santos C. Validation study of the Portuguese version of the QLC-C30-V.3. Psicologia, Saúde e Doenças. 2008; 9(1): 89–102.
IBM Corp. IBM SPSS Statistics for Windows, Version 29.0. IBM Corp; 2022.
Yang Y, Sun H, Luo X, et al. Network connectivity between fear of cancer recurrence, anxiety, and depression in breast cancer patients. Journal of Affective Disorders. 2022; 309: 358–367.
van de Wal M, van de Poll-Franse L, Prins J, Gielissen M. Does fear of cancer recurrence differ between cancer types? A study from the population-based PROFILES registry. Psycho-Oncology. 2016; 25(7): 772–778.
Adashek JJ, Jordan A, Redwine LS, et al. Pan-cancer analysis of fear of cancer recurrence among cancer survivors. ESMO Open. 2022; 7(4).
Pang C, Humphris G. The Relationship Between Fears of Cancer Recurrence and Patient Gender: A Systematic Review and Meta-Analysis. Frontiers in Psychology. 2021; 12.
Smith AB, Costa D, Galica J, et al. Spotlight on the Fear of Cancer Recurrence Inventory (FCRI). Psychology Research and Behavior Management. 2020; 13: 1257–1268.
Cohee AA, Adams RN, Johns SA, et al. Long-term fear of recurrence in young breast cancer survivors and partners. Psycho-Oncology. 2017; 26(1): 22–28.